ES8602028A1 - Procedimiento para la obtencion de derivados del acido meti-lendifosfonico - Google Patents

Procedimiento para la obtencion de derivados del acido meti-lendifosfonico

Info

Publication number
ES8602028A1
ES8602028A1 ES539833A ES539833A ES8602028A1 ES 8602028 A1 ES8602028 A1 ES 8602028A1 ES 539833 A ES539833 A ES 539833A ES 539833 A ES539833 A ES 539833A ES 8602028 A1 ES8602028 A1 ES 8602028A1
Authority
ES
Spain
Prior art keywords
alkyl
derivatives
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539833A
Other languages
English (en)
Spanish (es)
Other versions
ES539833A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8602028A1 publication Critical patent/ES8602028A1/es
Publication of ES539833A0 publication Critical patent/ES539833A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Detergent Compositions (AREA)
  • Fireproofing Substances (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES539833A 1984-01-26 1985-01-25 Procedimiento para la obtencion de derivados del acido meti-lendifosfonico Granted ES539833A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8401214A FR2558837B1 (fr) 1984-01-26 1984-01-26 Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant

Publications (2)

Publication Number Publication Date
ES8602028A1 true ES8602028A1 (es) 1985-11-16
ES539833A0 ES539833A0 (es) 1985-11-16

Family

ID=9300506

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539833A Granted ES539833A0 (es) 1984-01-26 1985-01-25 Procedimiento para la obtencion de derivados del acido meti-lendifosfonico

Country Status (30)

Country Link
US (1) US4876247A (enExample)
EP (1) EP0151072B1 (enExample)
JP (1) JPS60174792A (enExample)
KR (1) KR850005449A (enExample)
AT (1) ATE32900T1 (enExample)
AU (1) AU570764B2 (enExample)
CA (1) CA1263397A (enExample)
CS (2) CS247199B2 (enExample)
DD (1) DD233847A5 (enExample)
DE (1) DE3561819D1 (enExample)
DK (1) DK168573B1 (enExample)
EG (1) EG16903A (enExample)
ES (1) ES539833A0 (enExample)
FI (1) FI77664C (enExample)
FR (1) FR2558837B1 (enExample)
GR (1) GR850160B (enExample)
HU (1) HU192664B (enExample)
IE (1) IE57971B1 (enExample)
IL (1) IL74117A (enExample)
MA (1) MA20331A1 (enExample)
NO (1) NO161678C (enExample)
NZ (1) NZ210945A (enExample)
OA (1) OA07941A (enExample)
PH (1) PH20913A (enExample)
PL (3) PL142493B1 (enExample)
PT (1) PT79859B (enExample)
SG (1) SG43289G (enExample)
SU (3) SU1382402A3 (enExample)
YU (2) YU11785A (enExample)
ZA (1) ZA85390B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
EP0491374B1 (en) * 1990-12-19 1996-01-31 Takeda Chemical Industries, Ltd. Bisphosphonic acid derivatives, their production and use
DK0594857T3 (da) * 1991-09-05 1998-10-07 Toray Industries Methandiphosphonsyrederivat, fremstilling deraf ogmedicinsk anvendelse deraf
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
EP0642521A1 (en) * 1992-05-29 1995-03-15 Procter & Gamble Pharmaceuticals Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
PL175475B1 (pl) * 1992-05-29 1999-01-29 Procter & Gamble Pharma Nowe zawierające siarkę związki fosfonianowe
CZ297094A3 (en) * 1992-05-29 1995-12-13 Procter & Gamble Pharma Phosphate compounds containing quaternary nitrogen, their use and pharmaceutical compositions containing thereof
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
JPH07508279A (ja) * 1992-06-30 1995-09-14 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド ホスホネート類及びnsaidを含有した関節炎の治療用組成物
KR100272907B1 (ko) * 1992-07-10 2001-03-02 히라이 가쯔히꼬 메탄디포스폰산 유도체, 이의 제조방법 및 이의 의약 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1958123C3 (de) * 1969-11-19 1978-09-28 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen
DE2115737C3 (de) * 1971-03-31 1979-11-08 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 - Aminoalkan-1,1 -diphosphonsäuren
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4100167A (en) * 1977-05-09 1978-07-11 Nalco Chemical Company Production of 1-aminoalkane-1, 1-diphosphonic acids using phosphorous acid and nitriles in a non-aqueous system
DE2754821C3 (de) * 1977-12-09 1981-08-13 Benckiser-Knapsack Gmbh, 6802 Ladenburg Verfahren zur Herstellung von 1-Aminoalkan-1,1-diphosphonsäuren
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation

Also Published As

Publication number Publication date
FR2558837B1 (fr) 1986-06-27
OA07941A (fr) 1987-01-31
SU1410865A3 (ru) 1988-07-15
YU113787A (en) 1988-04-30
DD233847A5 (de) 1986-03-12
AU3794085A (en) 1985-08-01
PL148892B1 (en) 1989-12-30
ATE32900T1 (de) 1988-03-15
AU570764B2 (en) 1988-03-24
IL74117A0 (en) 1985-04-30
FI77664B (fi) 1988-12-30
KR850005449A (ko) 1985-08-26
US4876247A (en) 1989-10-24
DE3561819D1 (en) 1988-04-14
GR850160B (enExample) 1985-05-23
EG16903A (en) 1989-06-30
NO850315L (no) 1985-07-29
IL74117A (en) 1989-02-28
PL251700A1 (en) 1985-09-10
EP0151072A3 (en) 1985-08-21
SU1382402A3 (ru) 1988-03-15
NO161678B (no) 1989-06-05
EP0151072B1 (fr) 1988-03-09
FI850319A0 (fi) 1985-01-24
CS247199B2 (en) 1986-12-18
PT79859B (fr) 1986-10-23
HUT38362A (en) 1986-05-28
FI850319L (fi) 1985-07-27
PH20913A (en) 1987-05-28
SG43289G (en) 1989-12-22
PT79859A (fr) 1985-02-01
DK168573B1 (da) 1994-04-25
SU1419520A3 (ru) 1988-08-23
NO161678C (no) 1989-09-13
YU11785A (en) 1987-12-31
JPH0455436B2 (enExample) 1992-09-03
EP0151072A2 (fr) 1985-08-07
JPS60174792A (ja) 1985-09-09
DK29285A (da) 1985-07-27
IE850140L (en) 1985-07-26
ZA85390B (en) 1985-08-28
FI77664C (fi) 1989-04-10
PL142493B1 (en) 1987-10-31
PL144353B1 (en) 1988-05-31
CA1263397A (en) 1989-11-28
HU192664B (en) 1987-06-29
MA20331A1 (fr) 1985-10-01
NZ210945A (en) 1987-06-30
IE57971B1 (en) 1993-06-02
DK29285D0 (da) 1985-01-22
ES539833A0 (es) 1985-11-16
FR2558837A1 (fr) 1985-08-02
CS247192B2 (en) 1986-12-18

Similar Documents

Publication Publication Date Title
ES8602028A1 (es) Procedimiento para la obtencion de derivados del acido meti-lendifosfonico
ES8206523A1 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclo- propil-4-oxo-1,4-dihidro-naftirin-3-carboxilicos
ES472384A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina
DE69006872D1 (de) 1H,3H,7-Pyrrolo [1,2-c]thiazolcarbonsäureamid-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DK162646C (da) 3-(4-benzyl-piperazin-1-yl)-rifamycin sv- og s-forbindelser samt salte deraf, fremgangsmaade til fremstilling deraf og farmaceutiske sammensaetninger indeholdende disse forbindelser
ES8602716A1 (es) Procedimiento para la preparacion de derivados de tiazolidina.
DE3263727D1 (en) Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them
ES8604505A1 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
HUT40409A (en) Process for production of new bi-2h-piroli/di/n derivatives
DE3061561D1 (en) Phenyl piperazine derivatives, their preparation and antiagressive medicines containing them
DE3570874D1 (en) 1,4-dihydropyridine hydroxyamines, process for their preparation and their use as pharmaceutical agents
GB1461185A (en) Preparation of sulphonyl-benzamide derivatives
ES8604519A1 (es) Procedimiento para la preparacion de un nuevo derivado de lafenil-3 propeno-2 amina
ES8604132A1 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquiltiofenil)-2-amino-1,3-propandiol
ATE87625T1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh- chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
GB1455595A (en) Preparation of 2,5-disubstituted benzamides
GB1447329A (en) Preparation of sulphonyl-benzamide derivatives
ES8601695A1 (es) Procedimiento para la preparacion de compuestos de pteridina
DE3782228D1 (de) Acetylendiharndstoffderivate und ihre verwendung zum stabilisieren von kunststoffen.
ES8101045A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
ES8800141A1 (es) Un procedimiento para preparar un derivado de semicarbazida
ES483889A1 (es) Un procedimiento para la preparacion de un derivado de aci- doclavulanico.
ES364979A1 (es) Procedimiento para la preparacion de nuevas 3-amino-4-halo-geno - sidnoniminas.
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
PT73274A (en) Process for preparing new naphthimidazole and naphthoxazole derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001